Increased catabolic activity in adipose tissue of patients with chronic heart failure

European Journal of Heart Failure

Volumn 15, Issue 10, 2013, Pages 1131-1137

  Szabó, Tibor ^a   Postrach, Elisa ^a   Mähler, Anja ^a   Kung, Thomas ^a   Turhan, Guelistan ^a   Von Haehling, Stephan ^a   Anker, Stefan D ^a,b   Boschmann, Michael ^a   Doehner, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Cachexia; Glycolysis; Heart failure; Insulin resistance; Lipolysis; Metabolism; Microdialysis; Muscle; Natiuretic peptide

Indexed keywords

ANTICOAGULANT AGENT; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; INSULIN; LACTIC ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPOLYSIS; MALE; MICRODIALYSIS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE METABOLISM; TISSUE PERFUSION;

CACHEXIA; GLYCOLYSIS; HEART FAILURE; INSULIN RESISTANCE; LIPOLYSIS; METABOLISM; MICRODIALYSIS; MUSCLE; NATIURETIC PEPTIDE;

ADIPOSE TISSUE; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BLOOD GLUCOSE; CACHEXIA; CASE-CONTROL STUDIES; CHRONIC DISEASE; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCEROL; GLYCOLYSIS; HEART FAILURE; HUMANS; INSULIN; LACTIC ACID; LIPOLYSIS; MALE; MICRODIALYSIS; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 84885051569     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft067     Document Type: Article

References (34)

1. Cleland JGF, Khand A, Clark AC. The heart failure epidemic: exactly how big is it? Eur Heart J 2001;22:623-626. (Pubitemid 32622421)
2. Poehlman ET, Scheffers J, Gotlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994; 121:860-862.
3. Obisesan TO, Toth MJ, Donaldson K, Gottlieb SS, Fisher ML, Vaitekevicius P, Poehlman ET. Energy expenditure and symptom severity in men with heart failure. Am J Cardiol 1996;77:1250-1252. (Pubitemid 26186975)
4. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail 2012;14: 120-129.
5. Fülster S, Tacke M, Sandek A, Ebner N, Tschöpe C, Doehner W, Anker SD, von Haehling S. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2013;34:512-519
6. Anker SD, Ponikowski P, Varney S Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050-1053. (Pubitemid 27158249)
7. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJ. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997;30:527-532. (Pubitemid 27339335)
8. Doehner W, Rauchhaus M, Davos CH, Sharma R, Bolger A, Anker SD. Clinical significance of impaired insulin sensitivity in chronic heart failure. Circulation 2000; 102:719.
9. Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006;114:1829-1837. (Pubitemid 44673358)
10. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96:526-534. (Pubitemid 27329429)
11. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting inhibitors: an observational study. Lancet 2003; 361:1077-1083. (Pubitemid 36369559)
12. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 2003; 278:48617-48626. (Pubitemid 41079500)
13. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M, Berlan M. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 2001;42:536-544. (Pubitemid 32366996)
14. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005;90:3622-3628. (Pubitemid 41014335)
15. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Tank J, Diedrich A, Schroeder C, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J. Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J Clin Endocrinol Metab 2006;91:5069-5075. (Pubitemid 44917352)
16. Sengenes C, Zakaroff-Girard A, Moulin A, Berlan M, Bouloumie A, Lafontan M, Galitzky J. Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 2002;283:R257-R265. (Pubitemid 34863932)
17. Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, Franke G, Berlan M, Marques MA, Sweep FC, Luft FC, Lafontan M, Jordan J. Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 2008;57:3199-3204.
18. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur J Heart Fail 2012;14:803-869.
19. Jordan J, Tank J, Stoffels M, Franke G, Christensen NJ, Luft FC, Boschmann M. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 2001;86:2803-2810. (Pubitemid 32545743)
20. Fellander G, Linde B, Bolinder J. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 1996;20:220-226. (Pubitemid 26095354)
21. Doehner W, Todorovic J, Kennecke C, Rauchhaus M, Sandek A, Lainscak M, van Linthout S, Tschöpe C, von Haehling S, Anker SD. Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study. Int J Cardiol 2012; 161:137-142.
22. Morgenthaler NG, Struck J, Thomas B, Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 2004;50:234-236. (Pubitemid 38125732)
23. Szabo T, von Haehling S, Habedank D, Rauchhaus M, Lainscak M, Sandek A, Schefold J, Anker SD, Doehner W. Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure. Int J Cardiol 2011; 147:47-51.
24. Bernt E, Gutmann I. Ethanol determination with alcohol dehydrogenase and NAD. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Weinheim, Germany: Verlag Chemie 1974. p1499-1505.
25. Rosdahl H, Ungerstedt U, Jorfeldt L, Henriksson J. Interstitial glucose and lactate balance in human skeletal muscle and adipose tissue studied by microdialysis. J Physiol 1993;471: 637-657. (Pubitemid 23345600)
26. Arner P, Liljeqvist L, Ostman J. Metabolism of mono- and diacylglycerols in subcutaneous adipose tissue of obese and normal-weight subjects. Acta Med Scand 1976; 200:187-194.
27. Stahle L, Segersvard S, Ungerstedt U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J Pharmacol Methods 1991;25:41-52.
28. Enerbäck S. The origins of brown adipose tissue.NEngl J Med 2009;360:2021-2023.
29. Hagström E, Arner P, Ungerstedt U, Bolinder J. Subcutaneous adipose tissue: a significant source of lactate production after glucose ingestion in men.AmJ Physiol 1990; 258:E888-E893. (Pubitemid 20179452)
30. Ahmed K, Tunaru S, Tang C, Müller M, Gille A, Sassmann A, Hanson J, Offermanns S. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab 2010;11:311-319.
31. Polak J, Kotrc M,Wedellova Z, Jabor A, Malek I, Kautzner J, Kazdova L, MelenovskyV. Lipolytic effects of B-type natriuretic peptide1-32 in adipose tissue of heart failure patients compared with healthy controls. J Am Coll Cardiol 2011;58:1119-1125.
32. Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983;32:117-123. (Pubitemid 13180343)
33. Akimoto K, Miyata A, KangawaK, KogaY, HayakawaK, Matsuo H. Molecular forms of atrial natriuretic peptide in the atrium of patients with cardiovascular disease. J Clin Endocrinol Metab 1988;67:93-97.
34. von Haehling S, Doehner W, Anker SD. Revisiting the obesity paradox in heart failure: new insights? Eur J Heart Fail 2011;13:130-132.